Revenue,
USD 33.56 Bn
Forecast Year,
USD 69.94 Bn
CAGR, 2025 -
7.62%
Report Coverage
Worldwide
Subcutaneous Drug Delivery Devices Market Size Analysis
Subcutaneous Drug Delivery Devices Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prefilled Syringes | 13.17 | 14.09 | 15.15 | 16.19 | 17.62 | 18.19 | 19.65 | 23.22 | 24.98 | 26.71 | 26.19 |
| Pen Injectors | 4.13 | 4.64 | 4.96 | 5.37 | 5.93 | 5.97 | 6.18 | 6.73 | 6.86 | 7.69 | 11.35 |
| Auto-injectors | 3.33 | 3.58 | 3.71 | 4.24 | 4.19 | 5.20 | 5.93 | 5.39 | 6.36 | 7.16 | 6.36 |
| Wearable Injectors | 12.94 | 13.80 | 15.04 | 16.03 | 17.28 | 19.09 | 20.38 | 20.77 | 22.19 | 23.42 | 26.03 |
Subcutaneous Drug Delivery Devices Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diabetes | 9.62 | 10.38 | 11.35 | 11.89 | 12.54 | 13.58 | 15.24 | 16.48 | 16.56 | 18.91 | 19.95 |
| Oncology | 0.15 | 0.27 | 0.04 | 0.43 | 0.05 | 0.44 | 0.05 | 0.70 | 1.56 | 1.91 | 0.07 |
| Autoimmune Disorders | 20.19 | 21.63 | 23.43 | 24.90 | 27.22 | 29.45 | 31.62 | 31.95 | 34.13 | 37.71 | 41.83 |
| Others | 3.60 | 3.84 | 4.05 | 4.62 | 5.21 | 4.97 | 5.22 | 6.98 | 8.14 | 6.47 | 8.10 |
Subcutaneous Drug Delivery Devices Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail Pharmacies | 0.03 | 0.05 | 0.14 | 0.04 | 0.15 | 0.05 | 0.11 | 0.79 | 0.06 | 0.06 | 1.26 |
| Hospital Pharmacies | 14.37 | 15.55 | 16.62 | 18.07 | 19.22 | 20.52 | 22.57 | 23.17 | 25.49 | 28.49 | 31.61 |
| Online Pharmacies | 19.15 | 20.51 | 22.11 | 23.72 | 25.65 | 27.88 | 29.46 | 32.15 | 34.83 | 36.44 | 37.07 |
Subcutaneous Drug Delivery Devices Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 12.41 | 13.33 | 14.18 | 15.12 | 16.74 | 18.30 | 19.97 | 20.59 | 22.02 | 24.21 | 27.74 |
| Europe | 16.60 | 17.89 | 19.25 | 20.64 | 22.54 | 23.82 | 26.33 | 28.18 | 29.54 | 33.29 | 32.37 |
| Asia Pacific | 0.13 | 0.18 | 0.11 | 0.04 | 0.04 | 0.06 | 0.10 | 0.06 | 0.77 | 0.07 | 0.07 |
| Latin America | 1.56 | 1.62 | 1.88 | 2.15 | 1.85 | 1.95 | 1.54 | 2.69 | 2.59 | 3.30 | 2.18 |
| Middle East & Africa | 2.85 | 3.09 | 3.44 | 3.88 | 3.84 | 4.32 | 4.20 | 4.59 | 5.46 | 4.12 | 7.59 |
Subcutaneous Drug Delivery Devices Market
Subcutaneous Drug Delivery Devices Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com